Methotrexate Toxicity: A Simple Solution to a Complex Problem
- PMID: 33972915
- PMCID: PMC8106237
- DOI: 10.7759/cureus.14364
Methotrexate Toxicity: A Simple Solution to a Complex Problem
Abstract
Methotrexate is a highly effective medication that is the mainstay of treatment for numerous complex dermatological and rheumatological disorders. However, its use requires close monitoring as it has serious side effects that could be fatal if not recognized promptly. Herein, we present an interesting case of methotrexate toxicity leading to a prolonged hospital stay with resultant increase in health care cost and patient dissatisfaction. It remains of pivotal importance for primary care physicians and hospitalists to be aware of its side effect profile. As such, early recognition of methotrexate toxicity can result in earlier initiation of goal-directed therapies, leading to improved outcomes and shorter hospital stay. Patient education and effective communication between health care providers and the patient are of utmost importance in ensuring patient safety.
Keywords: cost-effective; drug rash; methotrexate toxicity; neutropenia; patient-centered care.
Copyright © 2021, Asghar et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.JBI Database System Rev Implement Rep. 2015 Jan;13(1):76-87. doi: 10.11124/jbisrir-2015-1072. JBI Database System Rev Implement Rep. 2015. PMID: 26447009
-
Primary care attitudes to methotrexate monitoring.Qual Prim Care. 2012;20(6):443-7. Qual Prim Care. 2012. PMID: 23540824
-
Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines.PLoS One. 2018 Mar 23;13(3):e0194401. doi: 10.1371/journal.pone.0194401. eCollection 2018. PLoS One. 2018. PMID: 29570708 Free PMC article. Clinical Trial.
-
The practical use of methotrexate in psoriasis.Drugs. 1990 Nov;40(5):697-712. doi: 10.2165/00003495-199040050-00005. Drugs. 1990. PMID: 2292232 Review.
-
Patient-centered Care.Radiol Technol. 2009 Nov-Dec;81(2):133-47. Radiol Technol. 2009. PMID: 19901351 Review.
Cited by
-
Potential Effect of Etoricoxib in Reducing Inflammation in Methotrexate-Induced Pulmonary Injury in Rats: Role of Oxidative Stress and the TLR4/p38-MAPK/NF-κB Signaling Pathway.Inflammation. 2025 Aug;48(4):2407-2416. doi: 10.1007/s10753-024-02198-w. Epub 2024 Nov 27. Inflammation. 2025. PMID: 39602008 Free PMC article.
-
A Case Report on Iatrogenic Methotrexate Toxicity.Cureus. 2024 Jul 8;16(7):e64081. doi: 10.7759/cureus.64081. eCollection 2024 Jul. Cureus. 2024. PMID: 39114248 Free PMC article.
-
Fatal Neutropenia Sepsis Following Acute Methotrexate Toxicity.Cureus. 2025 Jan 21;17(1):e77754. doi: 10.7759/cureus.77754. eCollection 2025 Jan. Cureus. 2025. PMID: 39981473 Free PMC article.
-
Low-dose methotrexate toxicity leading to pancytopenia: leucovorin as a rescue treatment.Proc (Bayl Univ Med Cent). 2024 Feb 8;37(2):339-343. doi: 10.1080/08998280.2023.2289299. eCollection 2024. Proc (Bayl Univ Med Cent). 2024. PMID: 38343452 Free PMC article.
-
A Clinical Case of Methotrexate Toxicity.J Med Cases. 2025 Aug 22;16(8):314-317. doi: 10.14740/jmc5159. eCollection 2025 Aug. J Med Cases. 2025. PMID: 40904756 Free PMC article.
References
-
- Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. Farber S, Diamond LK. N Engl J Med. 1948;238:787–793. - PubMed
-
- Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. Menter A, Korman NJ, Elmets CA, et al. https://doi.org/10.1016/j.jaad.2009.03.027. J Am Acad Dermatol. 2009;61:451–485. - PubMed
-
- The human proton-coupled folate transporter: biology and therapeutic applications to cancer. Desmoulin SK, Hou Z, Gangjee A, Matherly LH. https://doi.org/10.4161/cbt.22020. Cancer Biol Ther. 2012;13:1355–1373. - PMC - PubMed
-
- The mechanism of action of methotrexate. Cronstein BN. Rheum Dis Clin North Am. 1997;23:739–755. - PubMed
-
- Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers. Brown PM, Pratt AG, Isaacs JD. https://doi.org/10.1038/nrrheum.2016.175. Nat Rev Rheumatol. 2016;12:731–742. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials